RecruitingNCT06773650

Proper Dietary Management, Follow-up, and Lactase Enzyme Supplementation for Lactose Intolerance

Lactose Intolerance: a Guide to Proper Dietary Management, Follow-up, and Lactase Enzyme Supplementation


Sponsor

European Institute of Oncology

Enrollment

385 participants

Start Date

Jan 8, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Lactose intolerance (LI) is considered the clinical syndrome caused by lactose malabsorption (LM). It is possible to identify four causes of lactase deficiency defining four different types of LM: primary (genetic), secondary (acquired), congenital (alactasia), and developmental (in premature infants, so reversible). The aim of this protocol is to investigate through an anonymous online survey the knowledge of the Italian population on clinical, pathophysiological, diagnostic and therapeutic issues of lactose intolerance. Data collected will be divulgated through a publication for both people with IL and nutritionists, enriched with tables and flow charts, to improve the knowledge on lactose intolerance and to support people suffering from this condition. The results of this survey will guide subjects suspected of suffering from lactose intolerance towards a correct diagnosis and a better management.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Subjects must be adults (≥18 years of age)
  • Willingness to complete the online survey

Exclusion Criteria2

  • Subjects \<18 years of age
  • Subjects not available to answer the online survey

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCompletion of online survey

The online survey aims to reach a representative sample of the Italian population to identify their knowledge regarding LI


Locations(1)

European Institute of Oncology

Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06773650


Related Trials